Open Access
Performance standards for antimicrobial susceptibility testing
Reads0
Chats0
TLDR
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards.Abstract:
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards: M02-A12—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition; M07-A10—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Tenth Edition; and M11-A8—Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard— Eighth Edition. The standards contain information about both disk (M02) and dilution (M07 and M11) test procedures for aerobic and anaerobic bacteria. Clinicians depend heavily on information from the microbiology laboratory for treatment of their seriously ill patients. The clinical importance of antimicrobial susceptibility test results demands that these tests be performed under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. The tabular information presented here represents the most current information for drug selection, interpretation, and QC using the procedures standardized in the most current editions of M02, M07, and M11. Users should replace the tables published earlier with these new tables. (Changes in the tables since the previous edition appear in boldface type.) Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI supplement M100S (ISBN 1-56238-923-8 [Print]; ISBN 1-56238924-6 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2016. The data in the interpretive tables in this supplement are valid only if the methodologies in M02-A12—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition; M07-A10—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Tenth Edition; and M11-A8—Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard— Eighth Edition are followed.read more
Citations
More filters
Journal ArticleDOI
Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
TL;DR: The high-level resistance to β-lactams of this clinical isolate resulted from peculiar β- lactamases and modification of outer membrane proteins.
Journal ArticleDOI
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
TL;DR: The best-described form of PMQR is determined by the qnr group of genes, likely originating in aquatic organisms, which code for pentapeptide repeat proteins that reduce susceptibility to quinolones by protecting the complex of DNA and DNA gyrase or topoisomerase IV enzymes from the inhibitory effect of qu inolones.
Journal ArticleDOI
Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria
TL;DR: The history, taxonomy, geographic distribution, clinical disease, and therapy of the pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria (RGM) are reviewed and laboratory diagnosis of RGM using phenotypic methods such as biochemical testing and high-performance liquid chromatography and molecular methods of diagnosis are discussed.
Journal ArticleDOI
Incidence of Pneumococcal Disease Due to Non-Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998–2004
Lauri A. Hicks,Lee H. Harrison,Brendan Flannery,James L. Hadler,William Schaffner,Allen S. Craig,Delois Jackson,Ann Thomas,Bernard Beall,Ruth Lynfield,Arthur Reingold,Monica M. Farley,Cynthia G. Whitney +12 more
TL;DR: The incidence of pneumococcal disease caused by nonvaccine serotypes is increasing and Ongoing surveillance is needed to monitor the magnitude of disease cause by non vaccines, to ensure that future vaccines target the appropriate serotypes.
Journal ArticleDOI
Severe Community-Onset Pneumonia in Healthy Adults Caused by Methicillin-Resistant Staphylococcus aureus Carrying the Panton-Valentine Leukocidin Genes
John S. Francis,Meg Doherty,Uri Lopatin,Cecilia P. Johnston,Gita Sinha,Tracy Ross,Mian Cai,Nadia N. Hansel,Trish M. Perl,John R. Ticehurst,Karen C. Carroll,David L. Thomas,Eric L. Nuermberger,John G. Bartlett +13 more
TL;DR: These patients represent the first reported North American adults with severe community-onset MRSA pneumonia caused by strains carrying the PVL genes and belonged to the USA300 pulsed-field type.